» Articles » PMID: 12543936

The Regulatory Role of Valpha14 NKT Cells in Innate and Acquired Immune Response

Overview
Date 2003 Jan 25
PMID 12543936
Citations 254
Authors
Affiliations
Soon will be listed here.
Abstract

A novel lymphocyte lineage, Valpha14 natural killer T (NKT) cells, is now well established as distinct from conventional alphabeta T cells. Valpha14 NKT cells express a single invariant Valpha14 antigen receptor that is essential for their development. Successful identification of a specific ligand, alpha-galactosylceramide(alpha-GalCer), and the establishment of gene-manipulated mice with selective loss of Valpha14 NKT cells helped elucidate the remarkable functional diversity of Valpha14 NKT cells in various immune responses such as host defense by mediating anti-nonself innate immune reaction, homeostatic regulation of anti-self responses, and antitumor immunity.

Citing Articles

Eed-dependent histone modification orchestrates the iNKT cell developmental program alleviating liver injury.

Guo Y, Ohki S, Kawano Y, Kong W, Ohno Y, Honda H Front Immunol. 2024; 15:1467774.

PMID: 39372408 PMC: 11449725. DOI: 10.3389/fimmu.2024.1467774.


Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy.

Takami M, Motohashi S Front Immunol. 2024; 15:1457771.

PMID: 39224603 PMC: 11366658. DOI: 10.3389/fimmu.2024.1457771.


invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.

Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R Front Transplant. 2024; 3:1353803.

PMID: 38993780 PMC: 11235242. DOI: 10.3389/frtra.2024.1353803.


IL-27 regulates the differentiation of follicular helper NKT cells via metabolic adaptation of mitochondria.

Kamii Y, Hayashizaki K, Kanno T, Chiba A, Ikegami T, Saito M Proc Natl Acad Sci U S A. 2024; 121(9):e2313964121.

PMID: 38394242 PMC: 10907256. DOI: 10.1073/pnas.2313964121.


Lysosomal processing of sulfatide analogs alters target NKT cell specificity and immune responses in cancer.

Nishio K, Pasquet L, Camara K, DiSapio J, Hsu K, Kato S J Clin Invest. 2023; 134(4).

PMID: 38127463 PMC: 10866642. DOI: 10.1172/JCI165281.